Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA

Seiji Kondo, Yasuko Kondo, Guiying Li, Robert H. Silverman, John K. Cowell

Research output: Contribution to journalArticle

188 Citations (Scopus)

Abstract

Telomerase is the RNA-protein complex which elongates telomeric DNA (TTAGGG)(n) and appears to play an important role in cellular immortalization. The almost exclusive expression of telomerase in tumor cells, and not in most normal cells, offers an exciting opportunity for therapy by inhibiting its function. Here, we have investigated the effect of inhibition of telomerase on the growth and survival of human malignant glioma cells in vitro and in vivo by using a 19-mer antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate (2-5A). 2-5A antisense functions by activating the endoribonuclease, RNase L, resulting in the degradation of single stranded, targeted RNA. We have shown that the 2-5A antisense treatment effectively suppressed tumor cell growth and survival in vitro. Furthermore, treatment of tumors grown in nude mice with the antisense oligonucleotide inhibited survival of the tumor cells. TUNEL assays suggest that this effect is mediated through the induction of apoptosis. Targeting telomerase RNA with 2-5A antisense, therefore, may represent an effective and novel approach for treatment of a broad range of cancers.

Original languageEnglish (US)
Pages (from-to)3323-3330
Number of pages8
JournalOncogene
Volume16
Issue number25
DOIs
StatePublished - Jun 25 1998
Externally publishedYes

Fingerprint

Glioma
Antisense Oligonucleotides
Telomerase
Neoplasms
Cell Survival
Therapeutics
In Situ Nick-End Labeling
Growth
Nude Mice
telomerase RNA
2',5'-oligoadenylate
RNA
Apoptosis
Survival
DNA
Proteins
2-5A-dependent ribonuclease
In Vitro Techniques

Keywords

  • Apoptosis
  • Brain tumors
  • Nude mice
  • RNAse L
  • Telomerase

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. / Kondo, Seiji; Kondo, Yasuko; Li, Guiying; Silverman, Robert H.; Cowell, John K.

In: Oncogene, Vol. 16, No. 25, 25.06.1998, p. 3323-3330.

Research output: Contribution to journalArticle

Kondo, Seiji ; Kondo, Yasuko ; Li, Guiying ; Silverman, Robert H. ; Cowell, John K. / Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. In: Oncogene. 1998 ; Vol. 16, No. 25. pp. 3323-3330.
@article{3fd1179b53974c8a9adcfa7a6726e83f,
title = "Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA",
abstract = "Telomerase is the RNA-protein complex which elongates telomeric DNA (TTAGGG)(n) and appears to play an important role in cellular immortalization. The almost exclusive expression of telomerase in tumor cells, and not in most normal cells, offers an exciting opportunity for therapy by inhibiting its function. Here, we have investigated the effect of inhibition of telomerase on the growth and survival of human malignant glioma cells in vitro and in vivo by using a 19-mer antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate (2-5A). 2-5A antisense functions by activating the endoribonuclease, RNase L, resulting in the degradation of single stranded, targeted RNA. We have shown that the 2-5A antisense treatment effectively suppressed tumor cell growth and survival in vitro. Furthermore, treatment of tumors grown in nude mice with the antisense oligonucleotide inhibited survival of the tumor cells. TUNEL assays suggest that this effect is mediated through the induction of apoptosis. Targeting telomerase RNA with 2-5A antisense, therefore, may represent an effective and novel approach for treatment of a broad range of cancers.",
keywords = "Apoptosis, Brain tumors, Nude mice, RNAse L, Telomerase",
author = "Seiji Kondo and Yasuko Kondo and Guiying Li and Silverman, {Robert H.} and Cowell, {John K.}",
year = "1998",
month = "6",
day = "25",
doi = "10.1038/sj.onc.1201885",
language = "English (US)",
volume = "16",
pages = "3323--3330",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "25",

}

TY - JOUR

T1 - Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA

AU - Kondo, Seiji

AU - Kondo, Yasuko

AU - Li, Guiying

AU - Silverman, Robert H.

AU - Cowell, John K.

PY - 1998/6/25

Y1 - 1998/6/25

N2 - Telomerase is the RNA-protein complex which elongates telomeric DNA (TTAGGG)(n) and appears to play an important role in cellular immortalization. The almost exclusive expression of telomerase in tumor cells, and not in most normal cells, offers an exciting opportunity for therapy by inhibiting its function. Here, we have investigated the effect of inhibition of telomerase on the growth and survival of human malignant glioma cells in vitro and in vivo by using a 19-mer antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate (2-5A). 2-5A antisense functions by activating the endoribonuclease, RNase L, resulting in the degradation of single stranded, targeted RNA. We have shown that the 2-5A antisense treatment effectively suppressed tumor cell growth and survival in vitro. Furthermore, treatment of tumors grown in nude mice with the antisense oligonucleotide inhibited survival of the tumor cells. TUNEL assays suggest that this effect is mediated through the induction of apoptosis. Targeting telomerase RNA with 2-5A antisense, therefore, may represent an effective and novel approach for treatment of a broad range of cancers.

AB - Telomerase is the RNA-protein complex which elongates telomeric DNA (TTAGGG)(n) and appears to play an important role in cellular immortalization. The almost exclusive expression of telomerase in tumor cells, and not in most normal cells, offers an exciting opportunity for therapy by inhibiting its function. Here, we have investigated the effect of inhibition of telomerase on the growth and survival of human malignant glioma cells in vitro and in vivo by using a 19-mer antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate (2-5A). 2-5A antisense functions by activating the endoribonuclease, RNase L, resulting in the degradation of single stranded, targeted RNA. We have shown that the 2-5A antisense treatment effectively suppressed tumor cell growth and survival in vitro. Furthermore, treatment of tumors grown in nude mice with the antisense oligonucleotide inhibited survival of the tumor cells. TUNEL assays suggest that this effect is mediated through the induction of apoptosis. Targeting telomerase RNA with 2-5A antisense, therefore, may represent an effective and novel approach for treatment of a broad range of cancers.

KW - Apoptosis

KW - Brain tumors

KW - Nude mice

KW - RNAse L

KW - Telomerase

UR - http://www.scopus.com/inward/record.url?scp=0032566005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032566005&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1201885

DO - 10.1038/sj.onc.1201885

M3 - Article

C2 - 9681832

AN - SCOPUS:0032566005

VL - 16

SP - 3323

EP - 3330

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 25

ER -